Kou Longfa, Ph.D., Associate Professor, Deputy Chief Pharmacist, University-Appointed Researcher, and Doctoral Supervisor, specializes in innovative drug formulations driven by clinical challenges. His research focuses on critical clinical issues such as drug resistance in oncology, metabolic regulation in autoimmune diseases, and the treatment of acute inflammatory conditions. Dr. Kou has been recognized with several prestigious awards, including being selected as a High-Level Health Innovation Talent in Zhejiang Province, an Ouyue Science and Technology Leading Talent in Wenzhou City, and a member of the Outstanding Youth Training Project at Wenzhou Medical University. He has led over 10 scientific research projects at various levels, including grants from the National Natural Science Foundation of China and the Zhejiang Provincial Natural Science Foundation. As the first or corresponding author, he has published more than 60 SCI papers in top-tier international journals such as Journal of Controlled Release, Bioactive Materials, Chemical Engineering Journal, and Theranostics. With an H-index of 35, Dr. Kou was listed among the world's top 2% leading scientists based on "annual influence" in 2022, 2023, and 2024. He holds six authorized invention patents as the primary inventor. Additionally, Dr. Kou serves as a committee member for the Clinical Pharmacy Committee and the Pharmaceutics Committee of the Zhejiang Pharmaceutical Association, guest editor for Asian Journal of Pharmaceutical Sciences, young editorial board member for Central South Pharmacy and Drug Evaluation Research, and reviewer for multiple pharmaceutical journals.